hexamethylmelamin chemotherapi persist recurr epitheli ovarian cancer purpos studi activ toxic hexamethylmelamin chemotherapi patient persist recurr epitheli ovarian cancer forty-nin women hexamethylmelamin mg/day day interv patient chemotherapi regimen cisplatin patient measur diseas complet partial respons object respons rate mean progression-fre interv respond month month nonrespond patient nonmeasur diseas thirteen patient aliv clinic evid diseas patient therapi toxic reaction hexamethylmelamin well-toler drug activ ovarian cancer cisplatin 